Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes
Get Live Data
1,531.00    1.00 (0.07%)
Bid:
1,531.00
Ask:
1,532.00
Spread: 1.00 (0.065%)
Market Cap: £3.22b
HIK Live PriceLast checked at - London Stock Exchange

Intraday Hikma Pharmaceuticals Share Chart

Hikma Pharmaceuticals News

London close: Stocks finish lower as Ashtead announces US move
10 Dec 2024

London close: Stocks finish lower as Ashtead announces US move

(Sharecast News) - London stocks closed in negative territory on Tuesday, weighed down by a dip in sentiment following news that Ashtead planned to sh...

LONDON BROKER RATINGS: RBC raises Hikma; JPMorgan cuts Schroders
10 Dec 2024

LONDON BROKER RATINGS: RBC raises Hikma; JPMorgan cuts Schroders

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

RBC upgrades Hikma Pharmaceuticals to 'outperform'
10 Dec 2024

RBC upgrades Hikma Pharmaceuticals to 'outperform'

(Sharecast News) - Analysts at RBC Capital Markets upgraded Hikma Pharmaceuticals from 'sector perform' to 'outperform' on Tuesday as it took a look a...

LONDON BROKER RATINGS: RBC raises Ashtead; Deutsche Bank cuts Currys
3 Dec 2024

LONDON BROKER RATINGS: RBC raises Ashtead; Deutsche Bank cuts Currys

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

LONDON BROKER RATINGS: Deutsche Bank raises JD Sports and Weir
25 Nov 2024

LONDON BROKER RATINGS: Deutsche Bank raises JD Sports and Weir

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

Hikma Pharmaceuticals reiterates full-year guidance amid strong growth
7 Nov 2024

Hikma Pharmaceuticals reiterates full-year guidance amid strong growth

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday said it is on track to deliver "another strong performance" following trading to date, and rei...

Hikma reiterates outlook on strong trading
7 Nov 2024

Hikma reiterates outlook on strong trading

(Sharecast News) - Hikma Pharmaceuticals reiterated its full-year outlook on Thursday on the back of strong trading across the business.